Discover the Scientific Programme
The three day EASL NAFLD Summit 2023 has a full programme including:
- 9 plenary sessions
- 6 state-of-the-art lectures
- 4 parallel sessions
- 2 abstract sessions, and
- 6 ePosters sessions
Learning objectives
The EASL NAFLD Summit aims at updating you on the most recent advances in NAFLD research, both pre-clinically and clinically. You will gain insights in the most recent techniques employed in research, clinical trials and clinical practice, with an understanding of their potential as well as limitations. You will learn about the most recent advances in our understanding of the disease, including the role of sexual dimorphism, circadian clock or vascular mechanisms, and potential new targets as well as modalities of treatment. You will exchange on these topics with both young fellows and established experts in the field in a highly interactive format with a lot of room for discussion. You will get the latest update on where we stand with the efforts of having NAFLD on the agenda as a public health problem and the road map to tackle this problem, in which the people living with NAFLD and many stakeholders join forces. In light of the latter, the summit will also provide a space to further discuss the process of revising the NAFLD nomenclature. You will also get the latest data on diagnosis and prognostication in NASH and on how to tackle NASH as a multisystem disease, informing you not only on what you need to do, but also on the science and the data behind it.
Scope & Topics
- NAFLD diagnosis, recent advances in exploiting the liver biopsy and in biomarkers
- Controversial issues in the use of non-invasive tests
- NASH as a multisystem disease: multidirectional relations with diabetes, obesity and dyslipidaemia
- Novel therapeutic targets and modalities, including siRNA and gene targeting
- Awareness and public health issues
- The Wilton Park roadmap
- The process of revising the NAFLD nomenclature
- Research technologies and their application in NASH research
- Organoids in NAFLD research
- The microbiome in NAFLD: data and pitfalls
- Role of sexual dimorphism, circadian clock and vascular mechanisms
Session 1: To biopsy or not to biopsy, that's the question
Coming soon.
Session 2: Fatty liver disease awareness: a problem to solve
Coming soon.
Session 3: Breakthroughs in the disease formerly known as NAFLD: the nomenclature and beyond
Coming soon.
Session 4: Sexual dimorphism and circadian clock: new kids on the block
Coming soon.
Session 5: Chicken or the egg, Part 1: NAFLD and the cardiovascular system
Coming soon.
Session 6: - parallel sessions
- Challenging issues for the clinic and clinical trials
- Chicken or the egg, Part 2: NAFLD, dyslipidaemia and diabetes
Coming soon.
Session 7: Special techniques with their promises and pitfalls in NASH
Coming soon.
Session 8 - parallel sessions:
- The microbiome in NAFLD
- Stop the nitpicking and NIT
Coming soon.
Session 9: Pathways in NAFLD pathophysiology: beyond the usual suspects
Coming soon.
